SOPHiA GENETICS (SOPH) Work In Process (2020 - 2021)

SOPHiA GENETICS (SOPH) posted Work In Process of $1.3 million for Q4 2021, up 84.21% sequentially from $722000.0 in Q4 2020, and up 84.21% YoY from $722000.0 in Q4 2020.

SOPHiA GENETICS (SOPH) Work In Process (2020 - 2021) Analysis & Trends

SOPHiA GENETICS has reported Work In Process for 2 years, with the latest figure at $1.3 million in Q4 2021.

  • Quarterly Work In Process rose 84.21% year-over-year to $1.3 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $1.3 million (up 84.21% YoY) and the FY2021 annual result came in at $1.3 million, up 84.21% from the prior year.
  • Work In Process rose to $1.3 million in Q4 2021 per SOPH's latest filing, from $722000.0 in the prior quarter.
  • Over five years, Work In Process peaked at $1.3 million in Q4 2021 and troughed at $722000.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn
10 SOPHiA GENETICS 553.79 Mn 446.12 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 1.33 Mn
Dec 31, 2020 722,000.00